INTRONA, MARTINO
INTRONA, MARTINO
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Deep immunophenotypic characterization of CARCIK-CD19 pre-infusion cellular product by advanced multiparametric flow cytometry
2023 Buracchi, C; Belotti, D; Moretti, A; Calabretta, L; Risca, G; Capelli, C; Cabiati, B; Pedrini, O; Quaroni, M; Gotti, E; Matera, G; Cesana, S; Colombo, V; Rambaldi, B; Golay, J; Introna, M; Galimberti, S; Rambaldi, A; Biondi, A; Magnani, C; Gaipa, G
Epidemiological, Phenotypical, Histological and Genetic Characteristics of Patients with Multiple Melanomas: Study of 108 patients at ASST Papa Giovanni XXIII, Bergamo
2023 Carugno, A; Di Buduo, A; Perna, S; Barile, M; Sena, P; Introna, M
A comprehensive report of long-term stability data for a range ATMPs: A need to develop guidelines for safe and harmonized stability studies
2022 Capelli, C; Frigerio, S; Lisini, D; Nava, S; Gaipa, G; Belotti, D; Cabiati, B; Budelli, S; Lazzari, L; Bagnarino, J; Tanzi, M; Comoli, P; Perico, N; Introna, M; Golay, J
Optimization of therapeutic T cell expansion in G-Rex device and applicability to large-scale production for clinical use
2022 Gotti, E; Tettamanti, S; Zaninelli, S; Cuofano, C; Cattaneo, I; Rotiroti, M; Cribioli, S; Alzani, R; Rambaldi, A; Introna, M; Golay, J
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities
2020 Magnani, C; Gaipa, G; Lussana, F; Belotti, D; Gritti, G; Napolitano, S; Matera, G; Cabiati, B; Buracchi, C; Borleri, G; Fazio, G; Zaninelli, S; Tettamanti, S; Cesana, S; Colombo, V; Quaroni, M; Cazzaniga, G; Rovelli, A; Biagi, E; Galimberti, S; Calabria, A; Benedicenti, F; Montini, E; Ferrari, S; Introna, M; Balduzzi, A; Valsecchi, M; Dastoli, G; Rambaldi, A; Biondi, A
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System
2020 Rotiroti, M; Buracchi, C; Arcangeli, S; Galimberti, S; Valsecchi, M; Perriello, V; Rasko, T; Alberti, G; Magnani, C; Cappuzzello, C; Lundberg, F; Pande, A; Dastoli, G; Introna, M; Serafini, M; Biagi, E; Izsvák, Z; Biondi, A; Tettamanti, S
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation
2017 Introna, M; Lussana, F; Algarotti, A; Gotti, E; Valgardsdottir, R; Micò, C; Grassi, A; Pavoni, C; Ferrari, M; Delaini, F; Todisco, E; Cavattoni, I; Deola, S; Biagi, E; Balduzzi, A; Rovelli, A; Parma, M; Napolitano, S; Sgroi, G; Marrocco, E; Perseghin, P; Belotti, D; Cabiati, B; Gaipa, G; Golay, J; Biondi, A; Rambaldi, A
Development of advanced therapies in Italy: Management models and sustainability in six Italian cell factories
2016 Gaipa, G; Introna, M; Golay, J; Nolli, M; Vallanti, G; Parati, E; Giordano, R; Romagnoli, L; Melazzini, M; Biondi, A; Biagi, E
The Polo-Like Kinase 1 (PLK1) inhibitor NMS-P937 is effective in a new model of disseminated primary CD56+ acute monoblastic leukaemia
2013 Casolaro, A; Golay, J; Albanese, C; Ceruti, R; Patton, V; Cribioli, S; Pezzoni, A; Losa, M; Texido, G; Giussani, U; Marchesi, F; Amboldi, N; Valsasina, B; Bungaro, S; Cazzaniga, G; Rambaldi, A; Introna, M; Pesenti, E; Alzani, R